Product: | Adenosine-13C5 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | C19360 | ||||||||
CAS Number: | 159496-13-6 | ||||||||
Synonyms: |
9-β-D-Ribofuranosyl-9H-purin-6-amine-13C5; 9-β-D-Ribofuranosyladenine-13C5; Adenine Riboside-13C5; Adenocard-13C5; Adenocor-13C5; Adenogesic-13C5; Adenoscan-13C5; Adrekar-13C5; Boniton-13C5; D-Adenosine-13C5; 1-(6-Amino-9H-purin-9-yl)-1-deoxy-β-D |
||||||||
Pricing: |
|
||||||||
Formula: | C513C5H13N5O4 | ||||||||
Molecular Weight: | 272.2 | ||||||||
Structure: | |||||||||
Appearance: | White solid | ||||||||
Category: | Agonists | ||||||||
Literature References: |
Costa, F; Biaggioni, I., Role of nitric oxide in adenosine-induced vasodilation in humans. Hypertension, 1998, May, 31(5): 1061–4.; Morgan, JM; McCormack, DG; Griffiths, MJ; Morgan, CJ; Barnes, PJ; Evans, TW, Adenosine as a vasodilator in primary pulmonary hypertension.Circulation, 1991, Sept., 84(3): 1145–9.; Sato, A., Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. American journal of physiology. Heart and circulatory physiology, 2005, April, 288(4): H1633–40. |
||||||||
MSDS: | |||||||||
Description: | The labeled purine nucleoside compound composed of a molecule of adenine bonded to a ribose molecule. | ||||||||
Applications: | Plays an important role in energy transfer as ATP and ADP as well as in transduction as cAMP. It is also a neuromodulator that helps promote sleep and suppress arousal. Also regulates blood flow through vasodilation. Used as a medication to treat some forms of supraventricular tachycardia as an antiarrhythmic agent. |